Evidence map›Paper›PMID 41886495›Full record

ArticlePLoS pathogens2026

Herpesvirus-encoded lncRNA targets host splicing by interacting with splicing factors.

Yuan Hong, Ritu Shekhar, Sarah McMahon, Netanya Keil, Melody Baddoo, J Monty Watkins, Hasmik Keshishian, Caroline Stanclift, Steven A Carr, Mathias Munschauer and 3 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuan HongDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Ritu ShekharDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Sarah McMahonDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Netanya KeilDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.
Melody BaddooDepartment of Pathology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
J Monty WatkinsDepartment of Molecular Medicine, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation and Technology, Jupiter, Florida, United States of America.
Hasmik KeshishianBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Caroline StancliftBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Steven A CarrBroad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.
Mathias MunschauerDepartment of Infectious Diseases, Molecular Virology, Medical Faculty Heidelberg, Heidelberg University, Germany.
James M BurkeDepartment of Molecular Medicine, The Herbert Wertheim University of Florida Scripps Institute for Biomedical Innovation and Technology, Jupiter, Florida, United States of America.
Erik K FlemingtonDepartment of Pathology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Rolf RenneDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, United States of America.ORCID 0000-0001-7391-8806

Funding

NIH HHS NCI/P01 CA 214091
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes multiple short and long noncoding RNAs which contribute to viral latency, persistence, host gene regulation, and immune evasion. The Antisense-to-Latency Transcript (ALT) is a ~ 10 kb long noncoding RNA (lncRNA) located on the opposite strand of the major latency-associated region encoding the latency associated nuclear antigen, vCyclin, vFLIP, the Kaposin's and 12 microRNA genes. ALT is a nuclear lncRNA that is lowly expressed during latency, but strongly upregulated during lytic replication. Using RNA antisense purification and quantitative mass spectrometry (RAP-MS) in lytically induced primary effusion lymphoma cells, we identified 51 human and 3 viral proteins that directly interact with ALT. Of these enriched proteins, 48 are splicing factors, including core and alternative splicing proteins, such as U2AF2, PTBP1/2, SRSF1/3 and MBNL1. Interaction and co-localization of ALT was confirmed with various splicing factors in ribonucleoprotein complexes. We further identified that induction of lytic replication in lymphoid and epithelial cells leads to thousands of host gene splicing changes, which are partially restored upon perturbation of ALT expression. Finally, transient knockdown of ALT strongly inhibits viral reactivation and virion production. Hence, by splicing factors interactions, ALT interferes with host gene expression. Our results uncover a novel mechanism that shifts gene expression from the host to the virus late during the viral replication cycle to efficiently produce progeny virus and potentially antagonize host immune defenses.

Indexed as

Herpesvirus 8, HumanRNA, Long NoncodingRNA SplicingRNA Splicing FactorsRNA, ViralGene Expression Regulation, ViralHost-Pathogen InteractionsHumansViral ProteinsVirus LatencyVirus ReplicationRNA, Long NoncodingRNA Splicing FactorsRNA, ViralViral Proteins

Identifiers

PMID41886495
PMCPMC13056253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.